MustGrow Biologics Corp.
MGROF
$0.37
$0.00-0.16%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.45% | -72.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.45% | -72.18% | |||
| Cost of Revenue | 30.43% | -71.21% | |||
| Gross Profit | -157.70% | -77.82% | |||
| SG&A Expenses | -49.25% | 85.27% | |||
| Depreciation & Amortization | -1.03% | 1.04% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -29.76% | -17.19% | |||
| Operating Income | 43.00% | -162.55% | |||
| Income Before Tax | 14.64% | -124.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.64% | -124.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.64% | -124.13% | |||
| EBIT | 43.00% | -162.55% | |||
| EBITDA | 43.18% | -164.35% | |||
| EPS Basic | 20.50% | -113.25% | |||
| Normalized Basic EPS | 48.51% | -114.89% | |||
| EPS Diluted | 20.50% | -113.25% | |||
| Normalized Diluted EPS | 48.51% | -114.89% | |||
| Average Basic Shares Outstanding | 7.67% | 4.95% | |||
| Average Diluted Shares Outstanding | 7.67% | 4.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||